Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Opus Genetics, Inc. (IRD) had Debt to Capital Ratio of 0.15 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.08M |
|
$-17.45M |
|
-- |
|
$3.08M |
|
$11.39M |
|
$-8.31M |
|
$-9.14M |
|
$-17.45M |
|
$-17.45M |
|
$-17.45M |
|
$-17.45M |
|
$-17.45M |
|
$-17.45M |
|
$-8.31M |
|
$-8.30M |
|
70.64M |
|
70.64M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$35.91M |
|
$0.21M |
|
$0.21M |
|
$36.12M |
|
$29.09M |
|
$1.07M |
|
$1.07M |
|
$30.16M |
|
$5.97M |
|
$5.97M |
|
$5.97M |
|
64.54M |
|
| Cash Flow Statement Financials | |
$-25.42M |
|
-- |
|
$25.91M |
|
$30.32M |
|
$30.82M |
|
$0.49M |
|
$2.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.15 |
0.18 |
|
100.00% |
|
-269.93% |
|
-269.93% |
|
-- |
|
-566.87% |
|
-566.87% |
|
$-25.42M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
1.06 |
|
85.24 |
|
-292.51% |
|
-292.51% |
|
-48.32% |
|
-248.10% |
|
$0.09 |
|
$-0.36 |
|
$-0.36 |
|